Clinical Trials Logo

Clinical Trial Summary

The impact of oxygen therapy in many pathologies has been subject of recent work, arguing both favourable and harmful effects. Consequently, one can wonder about the influence of hyperoxic gas mixture during diving on the genesis of decompression sickness, but also about the systematic application of normobaric and hyperbaric oxygen in case of proven decompression sickness. In mammals, normoxic concentrations have been redefined at 20-100 mbars at the extracellular level and below 10 mbars in the mitochondria. Under hyperbaric conditions, most of the oxygen being dissolved in blood plasma, a state of hyperoxia is established which escapes the usual delivery and regulation system represented by red blood cells. The results of our team's previous work suggest a specific effect of diving on the levels of circulating mitochondrial DNA (mtDNA), suggesting cellular destruction linked to hyperoxia/hyperbaria. In fact, our studies, carried out on both animals and human divers, have shown that diving accident leads to an increase in mtDNA levels and an immune reaction through the mobilisation of leukocytes. The main objective of this study is to compare the influence of oxygen partial pressure levels on the evolution of clinical and biological variables during hyperbaric oxygen therapy sessions in healthy versus injured divers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04791488
Study type Interventional
Source Direction Centrale du Service de Santé des Armées
Contact Nicolas VALLEE, PhD
Phone 483162849
Email nicolas.vallee@intradef.gouv.fr
Status Recruiting
Phase N/A
Start date March 30, 2022
Completion date March 30, 2028

See also
  Status Clinical Trial Phase
Completed NCT02118207 - Exercise and Repetitive Diving N/A
Completed NCT02432131 - Decompression Sickness in Divers With or Without Patent Foramen Ovale
Completed NCT02468752 - Reduction of Venous Emboli Load After Breathing Normobaric Oxygen Compared to Air Phase 2/Phase 3
Recruiting NCT03192956 - Markers of Central Nervous System Injury in Decompression Sickness
Completed NCT02736006 - Decreases in Diffusing Lung Capacity for Carbon Monoxide (DLCO) in Occupational Divers and Their Impact on Decompression Sickness Risks N/A
Not yet recruiting NCT06370897 - Prediction & Mechanisms of Recovery Following IEDS
Not yet recruiting NCT06216366 - Rhu-pGSN to Mitigate Proinflammatory Responses to Decompression in Healthy SCUBA Divers Phase 2
Enrolling by invitation NCT02483650 - Hyperbaric Oxygen Therapy Registry
Completed NCT02064361 - High Intensity Cycling Before SCUBA Diving Reduces Post-decompression Microparticle Production and Neutrophil Activation N/A
Completed NCT03390335 - Decompression Tables for Diving at Altitude N/A
Completed NCT01587209 - Microparticles in Scuba Divers With Decompression Sickness N/A